FDA Inspection 1067763 — Vivex Biologics, Inc.
The FDA completed an inspection of Vivex Biologics, Inc. on September 21, 2018 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 21, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Miami, FL (United States)